PÉPTIDO C EN DIAGNÓSTICO Y DIFERENCIACIÓN DE DIABETES TIPO I Y TIPO II

Abstract

Diabetes mellitus is a chronic metabolic condition characterized by elevated blood glucose levels due to a deficiency in insulin production or action. In this context, C-peptide is a valuable biomarker to evaluate the function of pancreatic beta cells, which play a crucial role in the pathophysiology of diabetes mellitus. The objective is to analyze the role of C peptide in the diagnosis and differentiation between type I and type II diabetes, in order to evaluate its clinical usefulness and its potential impact on medical practice. An exhaustive investigation was carried out in different databases to identify studies related to the topic of interest. The studies reviewed indicated that C-peptide's ability to reflect beta cell function more accurately than insulin alone makes it especially attractive as a diagnostic and differentiation tool. It was concluded that C-peptide has promising potential as a biomarker. in the diagnosis and differentiatio n between type I and type II diabetes. However, more studies are required to validate its accuracy and clinical utility in different populations and clinical contexts.